Sep 16, 2026 06:57AM
Jul 1, 2026 07:00AM
Jun 22, 2026 06:59AM
Apr 30, 2026 06:54AM
Apr 14, 2026 06:48AM
Mar 27, 2026 06:47AM
Dec 8, 2025 06:46AM Ocular Therapeutix (OCUL) PT Raised to $21 at H.C. Wainwright
Oct 8, 2025 06:45AM
Sep 30, 2025 07:08AM
Sep 30, 2025 07:08AM
May 30, 2025 06:43AM
May 14, 2025 07:00AM
Mar 4, 2025 06:42AM
Dec 3, 2024 06:59AM H.C. Wainwright Reiterates Buy Rating on Ocular Therapeutix (OCUL)
Nov 15, 2024 06:51AM
Oct 16, 2024 06:54AM
Sep 4, 2024 07:30AM
Jun 14, 2024 07:57AM
May 8, 2024 06:49AM
Dec 18, 2023 04:01PM
Dec 14, 2023 03:49AM Ocular Therapeutix (OCUL) Prices 30.8M Share Offering at $3.25/sh
Dec 13, 2023 10:09PM
Sep 6, 2023 08:00AM
Aug 9, 2023 08:00AM
Feb 13, 2023 12:17PM
Sep 7, 2022 04:01PM
Aug 10, 2022 08:00AM
Jan 4, 2022 08:00AM Ocular Therapeutix™ to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Sep 13, 2021 06:47AM
Sep 13, 2021 06:45AM
Sep 7, 2021 08:00AM
Aug 10, 2021 08:00AM
Jul 23, 2021 09:19AM
Jul 22, 2021 05:51PM
Feb 24, 2021 08:00AM Ocular Therapeutix™ to Participate at Three Upcoming Investor Conferences
Sep 3, 2020 07:00AM
May 20, 2020 07:32AM
May 20, 2020 07:30AM
Feb 10, 2020 07:40AM
Apr 3, 2019 08:00AM
Aug 29, 2018 08:00AM
Jun 21, 2018 08:21AM Ocular Therapeutix (OCUL): Dextenza NDA Resubmission Imminent - HCWainwright
Mar 22, 2018 04:36PM
Jul 26, 2017 09:28AM
Jul 26, 2017 07:16AM
Oct 13, 2016 09:20AM

22,605 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All